Koning Corporation is expected to launch its Koning Breast Computed Tomography (KBCT) system, the first commercially available non-compression 3D breast CT scanner, later this month at the Radiological Society of North America (RSNA) 2015 annual meeting in Chicago. RSNA 2015 runs from Nov. 30 to Dec. 4.

The KBCT was approved as a diagnostic device by the FDA back in February, and is able to image the entire breast with one scan.

“For more than 35 years, breast imaging has been a 2D process only,” Ruola Ning, PhD, Koning president and founder, said in a statement. “The breast is one of the most difficult and complex organs to image—specialized training for radiologists is required to become proficient at detecting potential abnormalities. For the first time, we have regulatory approval and commercial availability of technology that improves the ability to visualize and evaluate breast tissue through the use of non-compression, isotropic 3D CT technology.”

According to Koning, approximately 1,000 scans were carried out on the KBCT at Elizabeth Wende Breast Care and the University of Rochester Medical Center, with some work also done at the UMass Memorial Medical Center.

A large study of those scans was then conducted at the Medical University of South Carolina (MUSC), led by Etta Pisano, MD, a radiologist, breast cancer researcher and former dean of the MUSC College of Medicine.

“It will be helpful to radiologists in identifying the true location of known lesions and providing diagnostic accuracy,” Pisano said in a statement. “I believe 3D imaging will supplant 2D imaging in the future.”